Forsyth Douglas insider trades
Forsyth Douglas has filed 9 Form 4s with the SEC that we hold, for Inhibrx Biosciences, Inc. (INBX) (Director) and INBX (Director). Across all of them we count 3 purchases worth $1.3M and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($286.6K) and 0 sales ($0). The largest single trade was a purchase of 59,812 shares of Inhibrx Biosciences, Inc. worth $841.6K, dated 2024-08-23. The first filing on our record is dated 2022-05-26 and the latest 2026-09-18.
Inhibrx Biosciences, Inc. (INBX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-08-22 | P, purchase reported on Form 4 | 15,188 | $195.8K | 2024-08-26 |
| 2024-08-23 | P, purchase reported on Form 4 | 59,812 | $841.6K | 2024-08-26 |
| 2026-09-08 | P, purchase reported on Form 4 | 2,500 | $286.6K | 2026-09-08 |
INBX (INBX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1240801) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms